Melissa Brown, managing director of applied research with Qontigo, joined Cheddar News to discuss a new start to the trading week as the market edged lower in a mixed-performance day. Investors also await the meeting between President Joe Biden and House Speaker Kevin McCarthy to look to resolve its debt ceiling debate.
Share:
More In Business
Chevron to Buy Hess for $53 Billion in Stock
Chevron announced Monday that it is buying Hess in a $53 billion all-stock deal.
JetBlue Plane Tilts Back After Landing at JFK Airport in New York but No Injuries Are Reported
JetBlue officials say a plane rocked back with its nose pointed skyward after landing at New York's John F. Kennedy International Airport because of a shift in weight on the aircraft.
Stocks Plummet After Treasury Yield Moves Above Key Level
Stocks fell after the 10-year Treasury yield moved above 5% with investors concerned following last week's remarks from Fed Chair Jerome Powell.
Chevron to Purchase Hess for $53 Billion
Chevron to Purchase Hess for $53 Billion
Big Business This Week: Rivian Raise, Costco CEO, Nokia Layoffs & More
Big Business This Week is a guided tour through the biggest market stories of the week, from winning stocks to brutal dips to the facts and forecasts generating buzz on Wall Street. This week we highlight Rivian, Costco, Nokia, Wyndham Hotels & Resorts, Choice Hotels and Rite Aid
Stretching Your Dollar: Explaining the New 'Girl Math' Personal Finance Trend
Tori Dunlap, founder of Her First $100K, joined Cheddar News to explain the new personal finance trend on social media known as 'Girl Math.'
Celebrities Willing to Pay More to End Strike
Celebrities Willing to Pay More to End Strike
Spirit Airlines Cancels Dozens of Flights to Inspect Some of Its Planes. Disruptions Will Last Days
Spirit Airlines canceled about 100 flights on Friday after pulling some planes out of service for inspections, and the airline expects the disruptions to last several days.
CVS Health Pulls Some Cough-and-Cold Treatments With Ingredient Deemed Ineffective by Doctors
CVS Health is pulling from its shelves some cough-and-cold treatments that contain an ingredient that has been deemed ineffective by doctors and researchers.
